abstract |
The present invention relates to new compounds of formula (IV) to their use in the treatment or prevention of diseases or conditions in which FLAP inhibition, including cardiovascular diseases (CVD), is beneficial, to methods for their therapeutic use, and to pharmaceutical compositions containing them. . |